Results 231 to 240 of about 173,569,965 (255)

Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines. [PDF]

Clin Pharmacol Ther
Jørgensen MJ, Gräf DD, Hallgreen CE.
europepmc   +1 more source

A Multiepitope Intranasal Adenoviral Vaccine Induces Robust Mucosal Immunity and Protection against SARS‑CoV‑2. [PDF]

J Nanobiotechnology
Elkashif A, Murala MST, Lee CM, Suresh R, Alhashimi M, Wang WC, Gairola V, Dos Santos AP, Boley PA, Schrock J, Kenney S, Sayedahmed EE, Renukaradhya GJ, Mittal SK.   +13 more
europepmc   +1 more source

MLL3 and MLL4 sustain hematopoietic stem cell multipotency by opposing a B-cell default state.

Blood
Wang HC, Chen R, Yang W, Muthukumar R, Hu T, Patel RM, Casey EB, Denby E, Zhang R, Xie G, Ge K, Challen GA, Bednarski JJ, Magee JA.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prediction of Efficiencies for Diverse Prime Editing Systems in Multiple Cell Types

Cell, 2023
Goosang Yu, Hyongbum Kim, Hui Kwon Kim
exaly  

Enhanced Prime Editing Systems by Manipulating Cellular Determinants of Editing Outcomes

Cell, 2021
Mustafa Şahin, Ci-Di Chen, Gregory A Newby   +2 more
exaly  

Phage-Assisted Evolution and Protein Engineering Yield Compact, Efficient Prime Editors

Cell, 2023
David R. Liu, Jessie Davis, Samagya Banskota   +2 more
exaly  

Engineered Prime Editors With PAM Flexibility

Molecular Therapy, 2021
Jong-Il Kim, Yongsub Kim, Jiyeon Kweon
exaly  

Prime Editing: A New Way for Genome Editing

Trends in Cell Biology, 2020
Marek Marzec, Goetz Hensel, Agnieszka Braszewska-Zalewska   +2 more
exaly